The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut.
Crohn’s disease
caco-2 cell
cannabidiol (CBD)
endocannabinoid system
gastrointestinal tract
inflammatory bowel disease (IBD)
microbiome
ulcerative colitis
Δ9-tetrahydrocannabinol (Δ9-THC)
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
26 Sep 2024
26 Sep 2024
Historique:
received:
19
08
2024
revised:
13
09
2024
accepted:
20
09
2024
medline:
15
10
2024
pubmed:
15
10
2024
entrez:
15
10
2024
Statut:
epublish
Résumé
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that exists in the
Identifiants
pubmed: 39404382
pii: cells13191618
doi: 10.3390/cells13191618
pii:
doi:
Substances chimiques
Cannabidiol
19GBJ60SN5
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : R25CA134283
Pays : United States
Organisme : NIH HHS
ID : R21AA031172
Pays : United States
Organisme : NIH HHS
ID : P50AA024337
Pays : United States
Organisme : NIH HHS
ID : P20GM113226
Pays : United States